AbbVie Signs Term Sheet For Potential Global Settlement Of AndroGel Cases
CHICAGO — AbbVie Inc., Abbott Laboratories and two related entities have entered into a confidential term sheet regarding a potential global settlement of claims involving AndroGel testosterone replacement therapy, according to...To view the full article, register now.
Already a subscriber? Click here to view full article